PHLDA2 and pancreatic adenocarcinoma: The results showed that there were significant correlations between a high frequency of PHLDA2 mRNA mutations and two clinicopathological features of PAAD: the invasion of surrounding tissues and tumor sites (p < 0.05) (Figure 3B,C).